Fig. 1
From: NKX2.5 is expressed in papillary thyroid carcinomas and regulates differentiation in thyroid cells
Panel with immunohistochemical expression of NKX2.5: (a), (b) Human heart tissue - positive control with nuclear and cytoplasmic immunostaining (10X, 20X); (c), (d) Human heart tissue - negative control without immunostaining (5X, 10X); (e), (f) Adjacent normal thyroid tissue - nuclear immunostaining (10X, 20X); (g), (h) Papillary thyroid carcinoma - absence of immunostaining (2X, 20X); (i), (j) Papillary thyroid carcinoma - high cytoplasmic immunostaining (2X, 20X); and (k), (l) Papillary thyroid carcinoma - low cytoplasmic immunostaining (5X, 10X)